Almaviva Group 2025 Financial Statements
May 2026

Almaviva SpA and Subsidiaries Consolidated Financial Statements for the Years ended December 31st, 2025 and 2024
March 2026

2025 Q4 Results Presentation
March 2026

Almaviva SpA and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the nine months ended September 30th, 2025 and 2024
November 2025

2025 Q3 Results Presentation
November 2025

Almaviva SpA and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30th, 2025 and 2024
August 2025

2025 Q2 Results Presentation
August 2025

Almaviva SpA and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the three months ended March 31st 2025 and 2024
May 2025

2025 Q1 Results Presentation
May 2025

Almaviva Group Financial Statements 2024
May 2025

Almaviva SpA and Subsidiaries Consolidated Financial Statements for the years ended December 31st 2024 and 2023
April 2025

2024 Q4 Results Presentation
April 2025

Almaviva S.p.A. and subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the nine months ended September 30th 2024 and 2023
November 2024

2024 Q3 Results Presentation
November 2024

AlmavivA S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30th, 2024 and 2023
August 2024

2024 Q2 Results Presentation
August 2024

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the three months ended March 31st, 2024 and 2023
May 2024

2024 Q1 Results Presentation
May 2024

Almaviva S.p.A. and Subsidiaries Consolidated Financial Statements for the years ended December 31, 2023 and 2022
March 2024

2023 Q4 Results Presentation
March 2024

AlmavivA S.p.A. and Subsidiaries Unaudited Int Condensed Consolidated Financial Statements September 30, 2023 and 2022
November 2023

2023 Q3 Results Presentation
November 2023

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30th, 2023 and 2022
August 2023

2023 Q2 Results Presentation
August 2023

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements March 31st 2023, and 2022
May 2023

2023 Q1 Results Presentation
May 2023

Almaviva S.p.A. and Subsidiaries Consolidated Financial Statements for the years ended December 31st, 2022 and 2021
March 2023

2022 Q4 Results Presentation
March 2023

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the nine months ended September 30th, 2022 and 2021
November 2022

2022 Q3 Results Presentation
November 2022

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30th, 2022 and 2021
August 2022

2022 Q2 Results Presentation
August 2022

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the three months ended March 31st, 2022 and 2021
May 2022

2022 Q1 Results Presentation
May 2022

Almaviva S.p.A. and Subsidiaries Consolidated Financial Statements for the years ended December 31st, 2021 and 2020
March 2022

2021 Q4 Results Presentation
March 2022

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the nine months ended September 30th, 2021 and 2020
November 2021

2021 Q3 Results Presentation
November 2021

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30th, 2021 and 2020
August 2021

2021 Q2 Results Presentation
August 2021

Almaviva S.p.A. and Subsidiaries Interim Condensed Consolidated Financial Report for the three months period ended March 31st, 2021
May 2021

2021 Q1 Results Presentation
May 2021

Almaviva S.p.A. and Subsidiaries Consolidated Financial Statements for the years ended December 31, 2020, 2019 and 2018
April 2021

2020 Q4 Results Presentation
April 2021

Almaviva S.p.A. and Subsidiaries Interim Consolidated Financial Report for nine months period ended 30 September 2020
November 2020

2020 Q3 Results Presentation
November 2020

Almaviva S.p.A. and Subsidiaries Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30th, 2020 and 2019
August 2020

2020 Q2 Results Presentation
August 2020

AlmavivA S.p.A. and Subsidiaries Interim Condensed Consolidated Financial Report for the three months period ended March 31st, 2020
May 2020

2020 Q1 Results Presentation
May 2020

Almaviva S.p.A. and Subsidiaries Consolidated Financial Statements for the years ended December 31, 2019, 2018 and 2017
March 2020

2019 Q4 Results Presentation
March 2020

Interim Consolidated Financial Report for nine months period ended 30 September 2019
November 2019

2019 Q3 Results Presentation
November 2019

Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30, 2019 and 2018
August 2019

2019 Q2 Results Presentation
August 2019

Interim Consolidated Financial Report for the three months period ended March 31 2019
May 2019

2019 Q1 Results Presentation
May 2019

Almaviva S.p.A. and Subsidiaries Consolidated Financial Statements for the years ended December 31, 2018, 2017 and 2016
March 2019

2018 Q4 and FY Results Presentation
March 2019

Interim Consolidated Financial Report for nine months period ended 30 September 2018
November 2018

2018 Q3 Results Presentation
November 2018

Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30, 2018 and 2017
September 2018

2018 Q2 Results Presentation
September 2018

Interim Consolidated Financial Report for the three months period ended March 31 2018
May 2018​

2018 Q1 Results Presentation
May 2018

Almaviva S.p.A. and Subsidiaries Consolidated Financial Statements for the years ended December 31, 2017, 2016 and 2015
March 2018​

2017 Q4 and FY Results Presentation
March 2018

Interim Consolidated Financial Report for nine months period ended 30 September 2017
November 2017

2017 Q3 Results Presentation
November 2017